脂质体布比卡因与盐酸布比卡因术后镇痛疗效比较:系统综述与Meta分析及试验序贯分析
该系统综述与Meta分析纳入23项随机对照试验共1867例患者,比较脂质体布比卡因与盐酸布比卡因的术后镇痛效果。主要终点为术后24和72小时疼痛评分差异及吗啡等效消耗量比值。结果显示脂质体布比卡因组术后24小时疼痛评分显著降低(-0.37,95%CI -0.56至-0.19),吗啡等效消耗比值显著降低(0.85,95%CI 0.82至0.89);72小时疼痛评分差异无统计学意义(-0.25,95%CI -0.71至0.20),吗啡等效消耗比值0.85(95%CI 0.77至0.95)。结论认为虽有统计学显著性,但临床获益较小且不具临床相关性。
要点
- 脂质体布比卡因术后24小时疼痛评分和吗啡消耗量均显著低于盐酸布比卡因,但差异幅度小。
- 术后72小时疼痛评分差异无统计学意义,吗啡消耗比值仍显著但临床相关性有限。
- 效应在所有研究中稳定,提示其不依赖于给药方式。
核心结论
- 脂质体布比卡因对术后疼痛评分和阿片类药物消耗的改善虽具统计学显著性,但幅度小且无临床相关性。
研究设计与样本
- 系统综述与Meta分析及试验序贯分析,纳入截至2020年5月在Embase、CENTRAL、MEDLINE和Web of Science检索的23项随机对照试验,共1867例患者。
主要发现
- 术后24小时疼痛评分差异为-0.37(95%CI -0.56至-0.19),脂质体布比卡因组显著更低。
- 术后24小时吗啡等效消耗量比值(ROM)为0.85(95%CI 0.82至0.89),脂质体布比卡因组显著更低。
- 术后72小时疼痛评分差异为-0.25(95%CI -0.71至0.20),无统计学显著性。
- 术后72小时吗啡等效消耗量比值(ROM)为0.85(95%CI 0.77至0.95)。
临床怎么用
- 脂质体布比卡因可小幅降低术后24小时疼痛评分和阿片消耗,但临床意义有限,不应期望显著改善结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/IMPORTANCE: Liposomal bupivacaine (LB) is a prolonged release formulation of conventional bupivacaine designed for prolonging local or peripheral regional single injection anesthesia. To this day, the benefit of the new substance on relevant end points is discussed controversial. OBJECTIVE: The objective was to determine whether there is a difference in postoperative pain scores and morphine consumption between patients treated with LB and bupivacaine hydrochloride in a systematic review and meta-analysis. EVIDENCE REVIEW: Randomized controlled trials (RCT) were identified in Embase, CENTRAL, MEDLINE and Web of Science up to May 2020. Risk of bias was assessed using Cochrane methodology. Primary end points were the mean pain score difference and the relative morphine equivalent (MEQ) consumption expressed as the ratio of means (ROM) 24 and 72 hours postoperatively. FINDINGS: 23 RCTs including 1867 patients were eligible for meta-analysis. The mean pain score difference at 24 hours postoperatively was significantly lower in the LB group, at -0.37 (95% CI -0.56 to -0.19). The relative MEQ consumption after 24 hours was also significantly lower in the LB group, at 0.85 (0.82 to 0.89). At 72 hours, the pain score difference was not significant at -0.25 (-0.71 to 0.20) and the MEQ ratio was 0.85 (0.77 to 0.95). CONCLUSION: The beneficial effect on pain scores and opioid consumption was small but not clinically relevant, despite statistical significance. The effect was stable among all studies, indicating that it is independent of the application modality.
引用
- Dinges HC, Wiesmann T, Otremba B, et al. The analgesic efficacy of liposomal bupivacaine compared with bupivacaine hydrochloride for the prevention of postoperative pain: a systematic review and meta-analysis with trial sequential analysis. Reg Anesth Pain Med. 2021. PMID: 33837139. doi:10.1136/rapm-2020-102427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。